Ellen Gendler, M.D.

Aging skin
Frank P; Gendler E
Current dermatologic diagnosis & treatment Philadelphia : Lippincott Williams & Wilkins, 2001,
— id: 3662, year: 2001, vol: , page: 10, stat: Chapter,

Hyaluronic acid for soft-tissue augmentation
Frank P; Gendler E
2001 Jan;28(1):121-126, Clinics in plastic surgery
— id: 21235, year: 2001, vol: 28, page: 121, stat: Journal Article,

A practical approach to the use of retinoids in aging skin
Gendler EC
1998 Aug;39(2 Pt 3):S114-S117, Journal of the American Academy of Dermatology
— id: 57152, year: 1998, vol: 39, page: S114, stat: Journal Article,

Topical treatment of the aging face
Gendler EC
1997 Oct;15(4):561-567, Dermatologic clinics
This article discusses the various over-the-counter and prescription products available to help improve sun-damaged skin, as well as superficial peeling agents. Practical suggestions for treating patients are given
— id: 12199, year: 1997, vol: 15, page: 561, stat: Journal Article,

Resurfacing with topical agents
Lewis AB; Gendler EC
1996 Sep;15(3):139-144, Seminars in cutaneous medicine & surgery
Evaluation of the aging face reveals many changes such as lentigines, coarseness, senile purpura, and fine lines that can be blamed primarily on photoaging. There are many topical preparations that are now being used or are under investigation for facial rejuvenation. These include retinold creams, alpha-hydroxy acids, Ethocyn (Chantal Skin Care Corp, Los Angeles, CA), topical vitamins, and topical hormonal treatments. There has been substantial media attention devoted to these 'antiaging' cures but there is a lack of scientific evidence to support some of these claims. After review of these agents, a practical approach to the patient requesting younger-looking skin is presented
— id: 16420, year: 1996, vol: 15, page: 139, stat: Journal Article,

Alstroemeria. A new and potent allergen for florists
Adams RM; Daily AD; Brancaccio RR; Dhillon IP; Gendler EC
1990 Jan;8(1):73-76, Dermatologic clinics
Alstroemeria (Peruvian or Inca lily) has found particular favor because of its beauty and durability. However, it may induce a dermatitis so severe that workers have to change jobs. The dermatitis is chronic, with fissuring at the tips of the fingers bilaterally. Itching is often a less prominent symptom. Preventative measures are of little benefit, and many floral shops are vanishing the plant
— id: 16206, year: 1990, vol: 8, page: 73, stat: Journal Article,

ADVERSE REACTIONS TO COSMETICS
Gendler, E
1987 Jun;39(6):525-526, Cutis
— id: 31321, year: 1987, vol: 39, page: 525, stat: Journal Article,

Herpes zoster: a possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals
Friedman-Kien AE; Lafleur FL; Gendler E; Hennessey NP; Montagna R; Halbert S; Rubinstein P; Krasinski K; Zang E; Poiesz B
1986 Jun;14(6):1023-1028, Journal of the American Academy of Dermatology
Zoster is uncommon before the age of 50 years in immunologically normal individuals, but it occurs with increased frequency in people who are immunosuppressed. A retrospective review of 300 patients with acquired immunodeficiency syndrome associated with Kaposi's sarcoma, revealed that 8% had prior zoster, a rate that is sevenfold greater than historic controls of the same age. We prospectively examined forty-eight patients, with no known immunodeficiency or signs of AIDS or AIDS related complex (ARC), who presented with zoster localized to the thoracic region. Forty-one patients had known risk factors for AIDS and thirty-five had antibody to the AIDS-associated virus (AAV) at the time of presentation. One seropositive subject had no known risk factors. Absolute lymphocyte counts, lymphocyte OKT4/OKT8 ratios, and lymphocyte mitogen responses were all depressed in subjects with antibody to AAV when compared with seronegative individuals. Seven of thirty-three AAV antibody-positive subjects, who could be followed longitudinally, developed AIDS from 1 to 28 months (mean = 13) after zoster. One antibody-negative subject seroconverted to become AAV seropositive 16 months after zoster and developed Kaposi's sarcoma 1 month later. These eight subjects had persistently low lymphocyte OKT4/OKT8 ratios and elevated beta-2 microglobulin. In patients at risk for AIDS, the occurrence of zoster may be one sign that heralds the marked depression of cellular immunity associated with AIDS or ARC
— id: 14781, year: 1986, vol: 14, page: 1023, stat: Journal Article,

HERPES-ZOSTER - A POSSIBLE EARLY CLINICAL SIGN FOR DEVELOPMENT OF AIDS IN HIGH-RISK INDIVIDUALS
FRIEDMANKIEN, AE; LAFLEUR, FL; GENDLER, E; HENNESSEY, NP; MONTAGNA, R; HALBERT, S; RUBINSTEIN, P; KRASINSKI, K; ZANG, E; POIESZ, B
1986 APR ;34(2):A750-A750, Clinical research
— id: 41417, year: 1986, vol: 34, page: A750, stat: Journal Article,

HERPES-ZOSTER - A POSSIBLE EARLY CLINICAL SIGN FOR DEVELOPMENT OF AIDS IN HIGH-RISK INDIVIDUALS
FRIEDMANKIEN, AE; LAFLEUR, FL; GENDLER, E; HENNESSEY, NP; MONTAGNA, R; HALBERT, S; RUBINSTEIN, P; KRASINSKI, K; ZANG, E; POIESZ, B
1986 APR ;86(4):475-475, Journal of investigative dermatology
— id: 41471, year: 1986, vol: 86, page: 475, stat: Journal Article,

AZATHIOPRINE FOR USE IN DERMATOLOGY
GENDLER, E
1984 ;10(6):462-464, Journal of dermatologic surgery & oncology
— id: 40795, year: 1984, vol: 10, page: 462, stat: Journal Article,